Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Cardiotoxicity in Newly Diagnosed Acute Myeloid Leukemia Patients: Anthracycline-Based Induction Versus Venetoclax - Hypomethylating Agent RegimensJ

NCT07851012 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT07851012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07851012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Cardiotoxicity in Newly Diagnosed Acute Myeloid Leukemia Patients: Anthracycline-Based Induction Versus Venetoclax - Hypomethylating Agent RegimensJ
Lead sponsor
Assiut University
Phase
Observational
Overall status
Not yet recruiting
Start date
October 14, 2026
Completion date
October 14, 2028
Enrollment
146 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

newly diagnosed acute myeloid leukemia (aml)